Skip to content
healthcare.dev

INFANRIX

NDC 58160-810, Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, suspension, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-810
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103647
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)10 [iU]/.5mL
  • CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)25 [iU]/.5mL
  • BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)25 ug/.5mL
  • BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)25 ug/.5mL
  • BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)8 ug/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Diphtheria Toxoid [CS]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Clostridium Tetani Vaccine [EPC]; Inactivated Corynebacterium Diphtheriae Vaccine [EPC]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Tetanus Toxoid [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
58160-810-525816008105210 SYRINGE in 1 CARTON (58160-810-52) / .5 mL in 1 SYRINGE (58160-810-43)

Linked data

RxNorm, label and prices

Use it

Look up 58160-810 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.